Literature DB >> 7701372

Chronic granulomatous disease--a report in two Malay families.

L Mohd Noh1, R M Noah, L L Wu, B A Nasuruddin, E Junaidah, C P Ooi, I Rose.   

Abstract

Chronic granulomatous disease (CGD) is a very rare disease whose defect lies in an abnormal intracellular killing resulting in recurrent abscesses, lymphadenitis and granuloma formation. We describe 2 Malay male infants with CGD whom we believe to be the first report of this disorder in Malays. Both children presented with recurrent abscesses, pneumoniae and hepatosplenomegaly; lymphadenopathy was also present in one of the patients. The organisms isolated were catalase positive bacteria. Both neutrophil chemiluminescence (against fungal and bacterial antigens, phorbol myristate acetate) and intracellular killing assays were severely depressed. Recognition of CGD is important as great strides have been made in the treatment of this disease which include gamma interferon therapy besides the conventional prophylactic antibacterial therapy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7701372

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  3 in total

1.  Synaptic plasticity deficits and mild memory impairments in mouse models of chronic granulomatous disease.

Authors:  Kenneth T Kishida; Charles A Hoeffer; Daoying Hu; Maryland Pao; Steven M Holland; Eric Klann
Journal:  Mol Cell Biol       Date:  2006-08       Impact factor: 4.272

2.  Malaysia's First Transplanted Case of Chronic Granulomatous Disease: The Journey of Overcoming Obstacles.

Authors:  Intan Hakimah Ismail; Faizah Mohamed Jamli; Ida Shahnaz Othman; Lokman Mohd Noh; Amir Hamzah Abdul Latiff
Journal:  Children (Basel)       Date:  2016-05-17

3.  Systematic Review of Primary Immunodeficiency Diseases in Malaysia: 1979-2020.

Authors:  Intan Juliana Abd Hamid; Nur Adila Azman; Andrew R Gennery; Ernest Mangantig; Ilie Fadzilah Hashim; Zarina Thasneem Zainudeen
Journal:  Front Immunol       Date:  2020-08-26       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.